U.S. Cannabis Market Size, Share, Growth and Forecast 2034
U.S. Cannabis Market Growth, Size, Trends Analysis - By Source, By Derivative, By Cultivation, By End-User - Regional Outlook, Competitive Strategies and Segment Forecast to 2034
| Published: Oct-2025 | Report ID: PHAR2533 | Pages: 1 - 148 | Formats*: |
| Category : Pharmaceutical | |||
U.S. Cannabis Market Introduction and Overview
According to SPER Market Research, the U.S. Cannabis Market is estimated to reach USD 119.79 billion by 2034 with a CAGR of 11.77%.
The report includes an in-depth analysis of the U.S. Cannabis Market, including market size and trends, product mix, Applications, and supplier analysis. The estimated size of the U.S. cannabis market was USD 39.37 billion in 2024, with a projected growth rate of 11.77% CAGR from 2025 to 2034. In the United States, cannabis finds applications in the pharmaceutical, cosmetic, and food & beverage sectors. The increasing acceptance of cannabis for medical use, along with the ongoing legalization efforts, are the primary drivers of market expansion. Furthermore, heightened research into cannabis and its therapeutic properties has resulted in its growing utilization for the treatment of various chronic ailments.
By Source Insights:
The marijuana market had the largest revenue share in 2024 and is projected to grow rapidly. This growth is driven by increased awareness of marijuana's therapeutic uses, including pain relief and appetite stimulation, as well as a shift in consumer attitudes toward recreational use. There is also a rising interest in marijuana-based skincare products for their ability to reduce inflammation and improve skin healing. The hemp segment is expected to see significant growth from 2025 to 2034 due to its nutritional value and beneficial fatty acid and protein profiles. Products infused with CBD from hemp are found in various categories, including nutritional powders, supplements, and pet food. Awareness of the health benefits of CBD is boosting demand for these products, and CBD is showing promising effects on pets, providing similar health benefits as it does for humans.
By Derivative Insights:
The CBD segment led the market by securing the largest revenue share in 2024. CBD, a non-psychoactive compound derived from the cannabis plant, is increasingly being adopted for various health concerns. Ongoing research highlights the potential advantages of CBD for specific health conditions. Meanwhile, the other segment also captured a notable revenue share in 2024 and is projected to experience the highest CAGR from 2025 to 2034. This segment encompasses other derivatives of the cannabis plant, including terpenes, flavonoids, and various minor cannabinoids. The rising popularity of minor cannabinoids, along with new product launches, is expected to drive growth in this segment.
By Cultivation Insights:
The indoor cultivation segment was the market leader, achieving the largest revenue share in 2024, and is forecasted to grow at the fastest CAGR throughout the projected period. Indoor cultivation involves growing cannabis in a controlled environment, such as a room, tent, or specially designated area that simulates natural conditions. Supportive government policies and the establishment of new indoor cannabis cultivation facilities are contributing to market expansion.
By End-User Insights:
The recreational use segment dominated the market with the largest revenue share in 2024 and is projected to grow at the fastest CAGR during the forecast period. This segment primarily encompasses cannabis consumption through smoking and its incorporation into food and beverages. Additionally, the legalization of cannabis for recreational use is accelerating the segment's growth. The medical use segment is also expected to see significant growth over the forecast period. Factors such as the increasing acceptance of cannabis for treating various chronic ailments, including diabetes, cancer, arthritis, depression, anxiety, and epilepsy, are contributing to the segment's expansion. The approval of cannabis-based medications for various conditions is further propelling this growth.
Regional Insights:
The U.S. cannabis market has been predominantly led by the West, with pioneering states such as California, Colorado, and Oregon at the forefront of legalization and the establishment of mature, high-value markets. Notably, California is often considered the largest cannabis market globally.
Market Competitive Landscape:
Key players within the U.S. cannabis market are fostering growth through strategic mergers and acquisitions, geographic expansion, and diversification of product lines. They are acquiring regional operators to bolster their market presence and optimize operations. By entering high-demand states and underserved areas, these companies are able to access new customer demographics. The diversification of product offerings, which includes edibles, beverages, and wellness items, is tailored to meet the changing preferences of consumers. Partnerships with well-known brands and celebrities contribute to enhancing brand visibility and trustworthiness.
Recent Developments:
In June 2024, Rodedawg International Industries, Inc., a manufacturer and distributor of cannabis products, launched the Nutrient CBD, which features five innovative SKUs, including two CBD Oil Tinctures, two CBD Creams, and one CBD Roll-On, designed to cater to the diverse needs of consumers looking for natural and effective wellness solutions.
In March 2023, CV Sciences, Inc. unveiled its latest product, +PlusCBD Daily Balance THC-Free Softgels and Gummies. This product serves as a convenient supplement for daily use, offering the wellness benefits of CBD.
Scope of the report:
| Report Metric | Details |
| Market size available for years | 2021-2034 |
| Base year considered | 2024 |
| Forecast period | 2025-2034 |
| Segments covered | By Source, By Derivative, By Cultivation, By End-User |
| Regions covered | Northeast, Midwest, West, South |
| Companies Covered | Medical Marijuana, Inc, NuLeaf Naturals, LLC, CV Sciences, Inc, CHARLOTTE’S WEB, The Cronos Group, Organigram Holding, Inc, Irwin Naturals, Tilray Brands, Canopy Growth Corporation, Aurora Cannabis. |
- U.S. Cannabis Market Size (FY 2021-FY 2034)
- Overview of U.S. Cannabis Market
- Segmentation of U.S. Cannabis Market By Source (Hemp, Marijuana)
- Segmentation of U.S. Cannabis Market By Derivatives (CBD, THC)
- Segmentation of U.S. Cannabis Market By Cultivation (Indoor Cultivation, Greenhouse Cultivation, Outdoor Cultivation)
- Segmentation of U.S. Cannabis Market By End User (Industrial Use, Medical Use, Recreational Use)
- Statistical Snap of U.S. Cannabis Market
- Expansion Analysis of U.S. Cannabis Market
- Problems and Obstacles in U.S. Cannabis Market
- Competitive Landscape in the U.S. Cannabis Market
- Details on Current Investment in U.S. Cannabis Market
- Competitive Analysis of U.S. Cannabis Market
- Prominent Players in the U.S. Cannabis Market
- SWOT Analysis of U.S. Cannabis Market
- U.S. Cannabis Market Future Outlook and Projections (FY 2025-FY 2034)
- Recommendations from Analyst
1. Introduction
- 1.1. Scope of the report
- 1.2. Market segment analysis
2. Research Methodology
- 2.1. Research data source
- 2.1.1. Secondary Data
- 2.1.2. Primary Data
- 2.1.3. SPERs internal database
- 2.1.4. Premium insight from KOLs
- 2.2. Market size estimation
- 2.2.1. Top-down and Bottom-up approach
- 2.3. Data triangulation
3. Executive Summary
4. Market Dynamics
- 4.1. Driver, Restraint, Opportunity and Challenges analysis
- 4.1.1. Drivers
- 4.1.2. Restraints
- 4.1.3. Opportunities
- 4.1.4. Challenges
5. Market variable and outlook
- 5.1. SWOT Analysis
- 5.1.1. Strengths
- 5.1.2. Weaknesses
- 5.1.3. Opportunities
- 5.1.4. Threats
- 5.2. PESTEL Analysis
- 5.2.1. Political Landscape
- 5.2.2. Economic Landscape
- 5.2.3. Social Landscape
- 5.2.4. Technological Landscape
- 5.2.5. Environmental Landscape
- 5.2.6. Legal Landscape
- 5.3. PORTERs Five Forces
- 5.3.1. Bargaining power of suppliers
- 5.3.2. Bargaining power of buyers
- 5.3.3. Threat of Substitute
- 5.3.4. Threat of new entrant
- 5.3.5. Competitive rivalry
- 5.4. Heat Map Analysis
6. Competitive Landscape
- 6.1. U.S. Cannabis Market Manufacturing Base Distribution, Sales Area, Product Type
- 6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in U.S. Cannabis Market
7. U.S. Cannabis Market, By Source (USD Million) 2021-2034
- 7.1. Hemp
- 7.1.1. Hemp Oil
- 7.1.2. Industrial Hemp
- 7.2. Marijuana
- 7.2.1. Flower
- 7.2.2. Oil and Tinctures
8. U.S. Cannabis Market, By Derivatives (USD Million) 2021-2034
- 8.1. CBD
- 8.2. THC
- 8.3. Others
9. U.S. Cannabis Market, By Cultivation (USD Million) 2021-2034
- 9.1. Indoor Cultivation
- 9.2. Greenhouse Cultivation
- 9.3. Outdoor Cultivation
10. U.S. Cannabis Market, By End User (USD Million) 2021-2034
- 10.1. Industrial Use
- 10.2. Medical Use
- 10.2.1. Chronic Pain
- 10.2.2. Depression and Anxiety
- 10.2.3. Arthritis
- 10.2.4. Post-Traumatic Stress Disorder (PTSD)
- 10.2.5. Cancer
- 10.2.6. Migraines
- 10.2.7. Epilepsy
- 10.2.8. Alzheimer’s Disease
- 10.2.9. Multiple Sclerosis
- 10.2.10. AIDS
- 10.2.11. Amyotrophic Lateral Sclerosis
- 10.2.12. Tourette’s Syndrome
- 10.2.13. Diabetes
- 10.2.14. Parkinson's Disease
- 10.2.15. Glaucoma
- 10.2.16. Others
- 10.3. Recreational Use
11.U.S. Cannabis Market, (USD Million) 2021-2034
- 11.1. U.S. Cannabis Market Size and Market Share
12. U.S. Cannabis Market, By Region, (USD Million) 2021-2034
- 12.1. Northeast
- 12.2. Midwest
- 12.3. West
- 12.4. South
13. Company Profile
- 13.1. Medical Marijuana, Inc
- 13.1.1. Company details
- 13.1.2. Financial outlook
- 13.1.3. Product summary
- 13.1.4. Recent developments
- 13.2. NuLeaf Naturals, LLC
- 13.2.1. Company details
- 13.2.2. Financial outlook
- 13.2.3. Product summary
- 13.2.4. Recent developments
- 13.3. CV Sciences, Inc
- 13.3.1. Company details
- 13.3.2. Financial outlook
- 13.3.3. Product summary
- 13.3.4. Recent developments
- 13.4. CHARLOTTE’S WEB
- 13.4.1. Company details
- 13.4.2. Financial outlook
- 13.4.3. Product summary
- 13.4.4. Recent developments
- 13.5. The Cronos Group
- 13.5.1. Company details
- 13.5.2. Financial outlook
- 13.5.3. Product summary
- 13.5.4. Recent developments
- 13.6. Organigram Holding, Inc
- 13.6.1. Company details
- 13.6.2. Financial outlook
- 13.6.3. Product summary
- 13.6.4. Recent developments
- 13.7. Irwin Naturals
- 13.7.1. Company details
- 13.7.2. Financial outlook
- 13.7.3. Product summary
- 13.7.4. Recent developments
- 13.8. Tilray Brands
- 13.8.1. Company details
- 13.8.2. Financial outlook
- 13.8.3. Product summary
- 13.8.4. Recent developments
- 13.9. Canopy Growth Corporation
- 13.9.1. Company details
- 13.9.2. Financial outlook
- 13.9.3. Product summary
- 13.9.4. Recent developments
- 13.10. Aurora Cannabis
- 13.10.1. Company details
- 13.10.2. Financial outlook
- 13.10.3. Product summary
- 13.10.4. Recent developments
- 13.11. Others
14. Conclusion
15. List of Abbreviations
16. Reference Links
SPER Market Research’s methodology uses great emphasis on primary research to ensure that the market intelligence insights are up to date, reliable and accurate. Primary interviews are done with players involved in each phase of a supply chain to analyze the market forecasting. The secondary research method is used to help you fully understand how the future markets and the spending patterns look likes.
The report is based on in-depth qualitative and quantitative analysis of the Product Market. The quantitative analysis involves the application of various projection and sampling techniques. The qualitative analysis involves primary interviews, surveys, and vendor briefings. The data gathered as a result of these processes are validated through experts opinion. Our research methodology entails an ideal mixture of primary and secondary initiatives.
Frequently Asked Questions About This Report
U.S. Cannabis Market is projected to reach USD 119.79 billion by 2034, growing at a CAGR of of 11.77% during the forecast period.
U.S. Cannabis Market grew in Market size from 2025. The Market is expected to reach USD 119.79 billion by 2034, at a CAGR of 11.77 billion% during the forecast period.
U.S. Cannabis Market CAGR of 11.77% during the forecast period.
You can get the sample pages by clicking the link - Click Here
U.S. Cannabis Market size is USD 119.79 billion from 2025 to 2034.
U.S. Cannabis Market is covered By Source, By Derivative, By Cultivation, By End-User
The Northeast, Midwest, West, South is the highest Market share in the U.S. Cannabis Market.
Medical Marijuana, Inc, NuLeaf Naturals, LLC, CV Sciences, Inc, CHARLOTTE’S WEB, The Cronos Group, Organigram Holding, Inc, Irwin Naturals, Tilray Brands, Canopy Growth Corporation, Aurora Cannabis.
The report includes an in-depth analysis of the U.S. Cannabis Market, including market size and trends, product mix, Applications, and supplier analysis.
PLACE AN ORDER
Year End Discount
Sample Report
Pre-Purchase Inquiry
NEED CUSTOMIZATION?
Request CustomizationCALL OR EMAIL US
100% Secure Payment
Related Reports
Have a glance of the Report
Our Global Clients
Our data-driven insights have influenced the strategy of 200+ reputed companies across the globe.
